Status:
COMPLETED
Increasing Human Papillomavirus (HPV) Vaccine Uptake Via General Health Messaging
Lead Sponsor:
University of California, Los Angeles
Collaborating Sponsors:
Cedars-Sinai Medical Center
Conditions:
Human Papilloma Virus
Eligibility:
FEMALE
21+ years
Phase:
NA
Brief Summary
Background: Prevention of cervical cancer and genital warts could be achieved by immunization with the prophylactic human papillomavirus (HPV) vaccines commercially available. However, in the U.S. onl...
Detailed Description
Prevention of cervical cancer and genital warts could be achieved by immunization with the prophylactic human papillomavirus (HPV) vaccines commercially available. However, in the U.S. only 38% of fem...
Eligibility Criteria
Inclusion
- Women who are patients at the clinic
- Age 21+
- Have a working mobile phone with SMS capability
Exclusion
- Male
- \<21 years of age
- Do not have a working mobile phone with SMS capability
Key Trial Info
Start Date :
April 25 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 19 2020
Estimated Enrollment :
3 Patients enrolled
Trial Details
Trial ID
NCT03759236
Start Date
April 25 2018
End Date
February 19 2020
Last Update
April 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California Los Angeles
Los Angeles, California, United States, 90095